These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36015271)

  • 21. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Liu F; Yang L; Li Y; Junier A; Ma F; Chen J; Han H; Glass Z; Zhao X; Kumamoto CA; Sang H; Xu Q
    ACS Biomater Sci Eng; 2020 Feb; 6(2):1064-1073. PubMed ID: 33464849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii.
    Batista-Duharte A; Lastre M; Romeu B; Portuondo DL; Téllez-Martínez D; Manente FA; Pérez O; Carlos IZ
    Int Immunopharmacol; 2016 Nov; 40():277-287. PubMed ID: 27639705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
    Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer.
    Shim YH; Kim YC; Lee HJ; Bougard F; Dubois P; Choi KC; Chung CW; Kang DH; Jeong YI
    J Microbiol Biotechnol; 2011 Jan; 21(1):28-36. PubMed ID: 21301189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unleashing Fungicidal Forces: Exploring the Synergistic Power of Amphotericin B-Loaded Nanoparticles and Monoclonal Antibodies.
    Souza CS; Lopes VRDC; Barcellos G; Alexandrino-Junior F; Neves PCDC; Patricio BFC; Rocha HVA; Ano Bom APD; Figueiredo ABC
    J Fungi (Basel); 2024 May; 10(5):. PubMed ID: 38786699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine Serum Albumin Nanoparticles Containing Amphotericin B: Characterization, Cytotoxicity and In Vitro Antifungal Evaluation.
    Casa DM; Karam TK; Alves Ade C; Zgoda AA; Khalil NM; Mainardes RM
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10183-8. PubMed ID: 26682465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
    J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B.
    Pedroso LS; Khalil NM; Mainardes RM
    Curr Drug Deliv; 2018; 15(7):1055-1063. PubMed ID: 29629661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity.
    Casa DM; Carraro TC; de Camargo LE; Dalmolin LF; Khalil NM; Mainardes RM
    J Nanosci Nanotechnol; 2015 Jan; 15(1):848-54. PubMed ID: 26328449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.
    Diezi TA; Takemoto JK; Davies NM; Kwon GS
    J Pharm Sci; 2011 Jun; 100(6):2064-70. PubMed ID: 21491436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphotericin B and Curcumin Co-Loaded Porous Microparticles as a Sustained Release System against
    Xue B; Yu Y; Peng G; Sun M; Lv P; Li X
    Molecules; 2022 May; 27(10):. PubMed ID: 35630555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.
    Nishi KK; Antony M; Mohanan PV; Anilkumar TV; Loiseau PM; Jayakrishnan A
    Pharm Res; 2007 May; 24(5):971-80. PubMed ID: 17372682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential amphotericin B delivery matrix.
    Richter AR; Carneiro MJ; de Sousa NA; Pinto VPT; Freire RS; de Sousa JS; Mendes JFS; Fontenelle ROS; Feitosa JPA; Paula HCB; Goycoolea FM; de Paula RCM
    Int J Biol Macromol; 2020 Jun; 152():492-502. PubMed ID: 32097738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres.
    Gharib A; Faezizadeh Z; Mohammad Asghari H
    Daru; 2011; 19(5):351-5. PubMed ID: 22615681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
    van Etten EW; ten Kate MT; Stearne LE; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1954-8. PubMed ID: 8540697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.